Literature DB >> 3100626

The B cell is the initiating antigen-presenting cell in peripheral lymph nodes.

C A Janeway, J Ron, M E Katz.   

Abstract

We have examined the role of B cells in antigen presentation in lymph nodes in several ways. We found that mice depleted of B lymphocytes via chronic injection of anti-mu-chain antibody do not mount peripheral lymph node T cell proliferative responses to normally immunogenic doses of antigen. Depletion of B cells by passage of immune lymph node cells over anti-immunoglobulin columns early after immunization depletes antigen-presenting function from draining lymph nodes, and this function can be restored by using B cells or splenic adherent cells to allow the remaining T cells to proliferate. Lymph node B cells present antigen very effectively to lines of antigen-specific T cells. However, unfractionated lymph node cells from anti-mu-treated mice present very poorly, if at all, whereas unfractionated spleen cells from the same mice do present antigen. This is in keeping with our previous finding that helper T cell function in the spleen is normal in B cell-deprived mice. Finally, when mice homozygous for the lymphoproliferative gene lpr are treated chronically with anti-mu-chain antibody, lymphadenopathy is greatly retarded, suggesting a role for B cells in the massive proliferation of T cells in this syndrome. From this analysis, it would appear that the initiating antigen-presenting cell in the lymph node is a B lymphocyte, and that B lymphocytes in lymph nodes may be distinct from those in the spleen. It is of interest that these results also suggest that the lymph node lacks an antigen-presenting cell that is found in the spleen, perhaps the dendritic cell.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3100626

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  78 in total

Review 1.  Perpetuation of immunological memory: a relay hypothesis.

Authors:  R Nayak; S Mitra-Kaushik; M S Shaila
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

2.  B cells and antibodies are required for resistance to the parasitic gastrointestinal nematode Trichuris muris.

Authors:  N M Blackwell; K J Else
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

3.  Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice.

Authors:  Shivaprakash Gangappa; Sharookh B Kapadia; Samuel H Speck; Herbert W Virgin
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

Review 4.  Treating human autoimmune disease by depleting B cells.

Authors:  R J Looney
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

Review 5.  Antigen presenting cells.

Authors:  D L Hamilos
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

6.  Intrathymic presentation by dendritic cells and macrophages: their role in selecting T cells with specificity for internal and external nominal antigen.

Authors:  M Zöller
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

Review 7.  B-cell involvement in the pathogenesis of RA-is there a contribution of the sympathetic nervous system?

Authors:  Georg Pongratz; Rainer H Straub
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 8.  Salmonella infection: Interplay between the bacteria and host immune system.

Authors:  Jonathan R Kurtz; J Alan Goggins; James B McLachlan
Journal:  Immunol Lett       Date:  2017-07-15       Impact factor: 3.685

9.  T-cell lymphokine response to orally administered proteins during priming and unresponsiveness.

Authors:  G F Hoyne; M G Callow; J Kuhlman; W R Thomas
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

10.  Induction of cellular immunity in chimpanzees to human tumor-associated antigen mucin by vaccination with MUC-1 cDNA-transfected Epstein-Barr virus-immortalized autologous B cells.

Authors:  G Pecher; O J Finn
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.